Developing Novel Therapeutic Approaches to Frailty

Author(s): John E. Morley

Journal Name: Current Pharmaceutical Design

Volume 15 , Issue 29 , 2009

Become EABM
Become Reviewer
Call for Editor


Frailty is now defined as a clinical entity and potentially responsive to medications. This article reviews the drugs available and those under development. While, at present, exercise is the primary therapy, it is expected over the next decade that numerous drugs will be available to treat components of the frailty syndrome.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2009
Page: [3384 - 3395]
Pages: 12
DOI: 10.2174/138161209789105045
Price: $65

Article Metrics

PDF: 20